- Home
- CTMX vs ATEX Comparison
CTMX vs ATEX Comparison
Compare CTMX & ATEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- ATEX
- Stock Information
- Founded
- CTMX 2008
- ATEX 1997
- Country
- CTMX United States
- ATEX United States
- Employees
- CTMX N/A
- ATEX N/A
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- ATEX Telecommunications Equipment
- Sector
- CTMX Health Care
- ATEX Telecommunications
- Exchange
- CTMX Nasdaq
- ATEX Nasdaq
- Market Cap
- CTMX 444.3M
- ATEX 468.9M
- IPO Year
- CTMX 2015
- ATEX N/A
- Fundamental
- Price
- CTMX $2.40
- ATEX $21.20
- Analyst Decision
- CTMX Strong Buy
- ATEX Buy
- Analyst Count
- CTMX 2
- ATEX 2
- Target Price
- CTMX $5.00
- ATEX $64.00
- AVG Volume (30 Days)
- CTMX 1.5M
- ATEX 207.2K
- Earning Date
- CTMX 08-07-2025
- ATEX 08-05-2025
- Dividend Yield
- CTMX N/A
- ATEX N/A
- EPS Growth
- CTMX 128.27
- ATEX N/A
- EPS
- CTMX 0.49
- ATEX N/A
- Revenue
- CTMX $147,557,000.00
- ATEX $6,031,000.00
- Revenue This Year
- CTMX N/A
- ATEX $5.17
- Revenue Next Year
- CTMX N/A
- ATEX $2.92
- P/E Ratio
- CTMX $4.97
- ATEX N/A
- Revenue Growth
- CTMX 23.81
- ATEX 43.90
- 52 Week Low
- CTMX $0.40
- ATEX $21.05
- 52 Week High
- CTMX $3.10
- ATEX $42.91
- Technical
- Relative Strength Index (RSI)
- CTMX 51.91
- ATEX 22.05
- Support Level
- CTMX $2.32
- ATEX $23.96
- Resistance Level
- CTMX $2.47
- ATEX $24.81
- Average True Range (ATR)
- CTMX 0.14
- ATEX 0.80
- MACD
- CTMX -0.01
- ATEX -0.15
- Stochastic Oscillator
- CTMX 17.89
- ATEX 3.99
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About ATEX Anterix Inc.
Anterix Inc is a United States-based company engaged in delivering broadband needed to modernize infrastructure for energy, transportation, logistics, and other industries. The company offers Private LTE for utilities which help to automate processes, monitor environmental conditions, enable artificial intelligence, and drive productivity.